For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...

Despite its rapid onset of action, zuranolone is expected to face challenges in Japan’s MDD ... Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from ...

Trump emphasised the urgent need for such a defense system, stating, "We need to immediately begin the construction of a state-of-the-art iron dome missile defence shield which will be able to ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them. The opioid crisis in the United States continues to cause chaos and ...

Praveg Limited was formerly incorporated as 'Sword & Shield Pharma Limited' on March 23 1992 with the Registrar of Companies Gujarat State. The Company obtained Certificate of Commencement on March 7 ...

“If these institutions encounter problems, investors relying on them may face losses without the protections self-custody provides,” Bourdon said, adding: “Over the long term, those in self ...

Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which specialises in iron deficiency, has announced that Anders Lundstrom has ...

The Sackler family members won’t receive a blanket shield from liability from civil lawsuits ... Thursday’s agreement is the latest from a major pharmaceutical-industry player that made, sold or ...

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts. This month’s cover feature examines the ...